Invasive Aspergillosis: Focus on New Approaches and New Therapeutic Agents
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
1
Page:
65-81
Author(s):
Johan Maertens, Koen Theunissen and Marc Boogaerts
Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
1
Page:
83-98
Author(s):
A. F. Nikkels and G. E. Pierard
Editorial
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
i-i
Author(s):
Antonio J. Grillo-Lopez, Anne McClure and Brian K. Dallaire
Non-Hodgkins Lymphoma: Review of Conventional Treatments
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
279-291
Author(s):
P. Multani, C.A. White and A. Grillo-Lopez
The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
293-300
Author(s):
R.O. Dillman
Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
301-311
Author(s):
A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White
Toxin-Labeled Monoclonal Antibodies
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
313-325
Author(s):
R.J. Kreitman
Radioimmunotherapy of B-Cell NHL
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
327-339
Author(s):
R.F. Meredith and S.J. Knox
Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
341-349
Author(s):
C. Krasner and R.M. Joyce
Antibody Therapy of Acute and Chronic Leukemias
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
357-367
Author(s):
Spero R. Cataland, Margaret Lucas and John C. Byrd